Generalized Anxiety Disorder 7

Generalized Anxiety Disorder 7 (GAD-7) is a self-reported questionnaire for screening and severity measuring of generalized anxiety disorder (GAD).[1] GAD-7 has seven items, which measure severity of various signs of GAD according to reported response categories with assigned points (see below). Assessment is indicated by the total score, which made up by adding together the scores for the scale all seven items.[2]

GAD-7 is a sensitive self-administrated test to assess generalized anxiety disorder,[3] normally used in outpatient and primary care settings for referral to psychiatrist pending outcome.[4] However, it cannot be used as replacement for clinical assessment and additional evaluation should be used to confirm a diagnosis of GAD.

The scale uses a normative system of scoring as shown below - [bullet points of answer options and points assigned] - with question at the end qualitatively describing severity of the patient's anxiety over the past 2 weeks.[4]

See also

External links

References

  1. Spitzer, RL; Kroenke, K; Williams, JB; Löwe, B (22 May 2006). "A brief measure for assessing generalized anxiety disorder: the GAD-7". Arch Intern Med. 166 (10): 1092–7. doi:10.1001/archinte.166.10.1092. PMID 16717171.
  2. Swinson, RP (December 2006). "The GAD-7 scale was accurate for diagnosing generalized anxiety disorder". Evid Based Med. 11 (6): 184. doi:10.1136/ebm.11.6.184. PMID 17213178.
  3. Kroenke, K; Spintzer, RL; Williams, JB; Monahan, PO; Löwe, B (6 March 2007). "Anxiety disorders in primary care: prevalence, impairment, comorbidity, and detection". Ann Intern Med. 146 (5): 317–25. doi:10.7326/0003-4819-146-5-200703060-00004. PMID 17339617.
  4. 1 2 Löwe B, Decker O, Müller S, Brähler E, Schellberg D, Herzog W, Herzberg PY (2008). "Validation and standardization of the Generalized Anxiety Disorder Screener (GAD-7) in the general population.". Med Care. 46 (3): 266–74. doi:10.1097/mlr.0b013e318160d093. PMID 18388841.


This article is issued from Wikipedia - version of the 5/26/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.